Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,518,008,348    

Indirect Value

   $7,546,182,718      
Total Shares   186,710,189      
Total Value   $10,064,191,065      


Neurocrine Biosciences Inc $704,088,488 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,110,150 Ligand Pharmaceuticals Inc $1,306,436,094 Curis Inc $3,390,252 Repligen Corp $455,929,095 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $704,088,488 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,110,150 Ligand Pharmaceuticals Inc $1,306,436,094 Curis Inc $3,390,252 Repligen Corp $455,929,095 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EPRS Epirus Biopharmaceuticals... 10% Owner   –       –       •   2008-10-06 3 IO $0.00 $0 D/D 0 4,107,899 -
CAPS Capstone Therapeutics Cor... 10% Owner   –       –       •   2008-10-07 3 IO $0.00 $0 D/D 0 3,950,288 -
ADLR Adolor Corp 10% Owner   –       –       •   2008-10-10 3 IO $0.00 $0 D/D 0 4,428,032 -
DVAX Dynavax Technologies Corp 10% Owner   –       –       •   2008-10-23 3 IO $0.00 $0 D/D 0 8,132,657 -
CRIS Curis Inc 10% Owner   –       –       •   2009-02-03 3 IO $0.00 $0 D/D 0 8,921,716 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2003-07-17 4 B $3.90 $2,340 I/I 600 2,424,023 1.42 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-31 4 B $2.95 $2,950 I/I 1,000 6,214,551 1.42 -
RGEN Repligen Corp Indirect Beneficial Owner   –       –       •   2009-07-07 4 S $5.50 $5,500 D/D (1,000) 2,765,050 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-31 4 S $2.70 $2,700 D/D (1,000) 5,239,447 0 -
ASTX Astex Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-05-06 4 S $2.75 $4,125 I/I (1,500) 5,764,193 0 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-10 4 B $2.79 $5,578 D/D 2,000 2,688,609 2.37 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-13 4 B $2.89 $6,361 D/D 2,200 2,690,809 2.37 -
CAPS Capstone Therapeutics Cor... Indirect Beneficial Owner   –       –       •   2008-10-13 4 B $0.63 $1,638 I/I 2,600 4,190,388 1.42 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-19 4 B $3.90 $13,260 I/I 3,400 4,857,915 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-07-08 4 B $4.25 $14,450 I/I 3,400 5,586,600 1.5 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-08-06 4 S $2.03 $7,103 D/D (3,500) 5,490,957 0 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-12 4 B $0.60 $2,159 I/I 3,600 8,285,799 1.42 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2009-01-26 4 B $2.00 $8,016 I/I 4,008 16,006,215 1.5 -
ASTX Astex Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-05-09 4 S $2.69 $11,573 I/I (4,300) 5,753,399 0 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-05-27 4 B $4.71 $23,556 I/I 5,000 5,032,700 1.5 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-06-18 4 S $5.52 $33,114 I/I (6,000) 1,502,351 -
ASTX Astex Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-05-07 4 S $2.71 $17,605 I/I (6,494) 5,757,699 0 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-26 4 B $0.49 $3,260 I/I 6,600 8,417,999 1.42 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2009-01-22 4 B $3.10 $21,390 I/I 6,900 5,937,547 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2009-01-15 4 B $3.05 $22,586 I/I 7,400 5,830,447 1.5 -
  195  Records found
  1  2   3   4   5   6   7   8      
  Page 1 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us